Meniere Disease Is a Heterogeneous Condition
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 6, 2024 -- Meniere disease is a heterogeneous condition with subgroups characterized by specific clinical features, according to a study published online Jan. 6 in The Laryngoscope.
John Phillips, Ph.D., from the Norfolk and Norwich University Hospitals NHS Foundation Trust in the United Kingdom, and colleagues conducted an observational study involving patients with Meniere disease to identify distinct clinical subtypes. Four hundred eleven patients were recruited into the study.
The researchers identified two main clusters: Cluster 1 was more likely to include patients diagnosed with ear infections (odds ratio, 0.30), while those reporting tinnitus in both ears, low pitched tinnitus, and stress as a trigger for vertigo attacks were significantly more likely to be in cluster 2 (odds ratios, 11.89, 21.09, and 14.94, respectively). Clustering in cluster 2 was significantly more likely for those diagnosed with benign paroxysmal positional vertigo, autoimmune disease, depression, migraines, drug allergy, and hay fever (odds ratios, 13.14, 5.97, 4.72, 3.13, 3.25, and 3.12, respectively).
"Appreciating how Meniere's disease may exist as a spectrum of clinical subtypes is key to directing further research into its underlying pathophysiologic mechanisms, to the targeting of specific treatment strategies, and to permitting a better understanding of the physiology of the inner ear microenvironment," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.